Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Artiva Biotherapeutics, Inc. - Common Stock (NQ: ARTV ) 14.78 +0.63 (+4.45%) Streaming Delayed Price Updated: 10:58 AM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 13,399 Open 14.18 Bid (Size) 14.58 (3) Ask (Size) 14.81 (3) Prev. Close 14.15 Today's Range 13.77 - 14.78 52wk Range 9.710 - 17.31 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference September 10, 2024 From Artiva Biotherapeutics, Inc. Via GlobeNewswire Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights August 29, 2024 From Artiva Biotherapeutics, Inc. Via GlobeNewswire Performance YTD +23.17% +23.17% 1 Month +25.36% +25.36% 3 Month +23.17% +23.17% 6 Month +23.17% +23.17% 1 Year +23.17% +23.17% More News Read More This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment August 29, 2024 Via The Motley Fool Topics Initial Public Offering Exposures Securities Market Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch August 13, 2024 Via Benzinga Topics Initial Public Offering Exposures Securities Market Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal July 27, 2024 Via Talk Markets Ardent Health Slips After Downsized IPO July 21, 2024 Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
